Steris (STE) Land & Improvements (2025 - 2026)
Steris (STE) recorded quarterly Land & Improvements of $112.3 million in Q1 2026, up 5.84% quarter-over-quarter from $106.1 million in Q1 2025, and up 5.84% on a YoY basis from $106.1 million in Q1 2025.
Steris (STE) Land & Improvements (2025 - 2026) Analysis & Trends
Steris' Land & Improvements history runs 2 years deep, the most recent figure standing at $112.3 million for Q1 2026.
- In Q1 2026, Land & Improvements rose 5.84% year-over-year to $112.3 million; the TTM figure through Mar 2026 stood at $112.3 million (up 5.84% YoY), while the FY2026 annual figure was $112.3 million, up 5.84% from the prior year.
- Land & Improvements was $112.3 million for Q1 2026 at Steris, up from $106.1 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $112.3 million in Q1 2026 to a low of $106.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.80 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 188.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 112.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.30 Mn |
| Mar 31, 2025 | 106.10 Mn |